Suchergebnisse - "IFN-β-1a"

PubPharm (10)

1

Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic

enthalten in: Acta neurologica Belgica | 2024

von Todorović, S. | Vojinović, S. | Savić, D. | +2

2

Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic

enthalten in: Acta neurologica Belgica | 2023

von Todorović, S. | Vojinović, S. | Savić, D. | +2

3

Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis : a real-world setting experience

enthalten in: Expert review of clinical pharmacology | 2018

von D'Amico, E. | Patti, F. | Zanghì, A. | +3

4

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration

enthalten in: Metabolism: clinical and experimental | 2017

von La Rocca, C. | Carbone, F. | De Rosa, V. | +15

5

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart® : the CORE study

enthalten in: BMC neurology | 2017

von Zecca, C. | Disanto, G. | Mühl, S. | +1

6

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

enthalten in: BMC neurology | 2017

von Zecca, C. | Disanto, G. | Mühl, S. | +1

7

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

enthalten in: BMC neurology | 2017

von Zecca, C. | Disanto, G. | Mühl, S. | +1

8

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

in: BMC Neurology | 2017

von Chiara Zecca | Giulio Disanto | Sarah Mühl | +1

9

Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)

enthalten in: Journal of neuroimmunology | 2016

von Tao, Y. | Zhang, X. | Markovic-Plese, S.

10

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

enthalten in: Neuroimmunomodulation | 2016

von Asadikaram, G. | Noroozi, S. | Ebrahimi Meimand, H. | +5

1
[1]